113 related articles for article (PubMed ID: 10063380)
21. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
Ortholan C; Romestaing P; Chapet O; Gerard JP
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
[TBL] [Abstract][Full Text] [Related]
22. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162
[TBL] [Abstract][Full Text] [Related]
23. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum.
Firat S; Erickson B
Gynecol Oncol; 2001 Feb; 80(2):213-20. PubMed ID: 11161862
[TBL] [Abstract][Full Text] [Related]
24. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy.
Chen J; Pappas L; Moeller JH; Rankin J; Sharma PK; Bentz BG; Fang LC; Hayes JK; Shrieve DC; Hitchcock YJ
Head Neck; 2007 Apr; 29(4):362-9. PubMed ID: 17163468
[TBL] [Abstract][Full Text] [Related]
25. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
[TBL] [Abstract][Full Text] [Related]
26. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
28. Recurrent rectal carcinoma treated with high-dose-rate intraluminal brachytherapy.
Kamikonya N; Hishikawa Y; Kurisu K; Taniguchi M; Miura T; Yanagi H; Kusunoki M; Utsunomiya J
Radiat Med; 1991; 9(2):88-90. PubMed ID: 1947206
[TBL] [Abstract][Full Text] [Related]
29. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
30. [The results of primary HDR-afterloading brachytherapy in corpus carcinoma].
Knocke TH; Kucera H; Weidinger B; Höller W; Pötter R
Strahlenther Onkol; 1995 Apr; 171(4):195-201. PubMed ID: 7740406
[TBL] [Abstract][Full Text] [Related]
31. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
[TBL] [Abstract][Full Text] [Related]
32. Recurrent rectal carcinoma treated with high dose rate intraluminal brachytherapy.
Begum N; Asghar AH; Shahida N; Jawad AG; Sher MK; Ayub K
J Coll Physicians Surg Pak; 2003 Sep; 13(9):528-9. PubMed ID: 12971877
[TBL] [Abstract][Full Text] [Related]
33. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
[TBL] [Abstract][Full Text] [Related]
35. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
Sorbe B; Söderström K
Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
[TBL] [Abstract][Full Text] [Related]
36. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
37. Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: multicentric experience.
Petera J; Soumarová R; Růzicková J; Neumanová R; Dusek L; Sirák I; Macingová Z; Paluska P; Kasaová L; Hodek M; Vosmik M
Ann Surg Oncol; 2010 Jan; 17(1):206-10. PubMed ID: 19711130
[TBL] [Abstract][Full Text] [Related]
38. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
39. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]